Desidustat in the Treatment of Chemotherapy Induced Anemia
Status:
Recruiting
Trial end date:
2021-09-10
Target enrollment:
Participant gender:
Summary
This is a Phase 1, Open-label, Single Dose, Study to Evaluate the Safety, Tolerability and
Pharmacokinetics of Desidustat for treatment of anemia in patients receiving chemotherapy.